GLP-1 medications essentially amplify and extend those satiety signals, making it easier to maintain a caloric deficit without the constant hunger that makes dietary restriction so difficult to sustain
And you and I both know, like, we decided to focus today on GLP 1s
Clinical data from semaglutide discontinuation studies reveal that patients who stopped without tapering experienced appetite increases averaging 70% higher than their baseline within two weeks
Should insulin resistance (HOMA-IR), insulin secretion (HOMA-), and visceral fat area be considered for improving the performance of diabetes risk prediction models
Ethics declarations Ethical approval Not applicable
This includes temperature-controlled transportation and storage, which can significantly elevate the overall cost of bringing these medications to patients